Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Currently, no prognostic stratification exists in stage IV pNET patients.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Marotta V
Authors: Marotta V, Malka D, Walter T, Do Cao C, Borget I,
Keywords: stage IV, pancreatic neuroendocrine tumor, prognosis, survival,
Introduction: Everolimus is an oral inhibitor of mammalian target of rapamycin(mTOR) with antitumor activity in patients(pts) with pancreatic neuroendocrine tumor(pNET)s
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Del Prete M
Authors: Del Prete M, Malka L, Borget I, Berdelou A, Boige V,
Keywords: Pancreatic Neuroendocrine Tumor, Everolimus, Safety,
Introduction: Treatment of well-differentiated (WD) lung neuroendocrine tumors (NETs) is challenging. Everolimus (mTOR inhibitor) has shown encouraging results in digestive NETs but data about its activity on lung carcinoid are sparse.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Gianoncelli L, Guigay J, Caramella C, Borget I, Mir O,
Keywords: lung carcinoid, everolimus, mTOR inhibitor,
#282 Characteristics of Patients with Well-differentiated Metastatic Lung Neuroendocrine Tumors
Introduction: Characteristics of well-differentiated lung neuroendocrine tumors (WDLNET) are poorly characterized at the metastatic stage.
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Chougnet C, Guigay J, Borget I, Leboulleux S, Duvillard P,
Keywords: lung NET, metastases, somatostatin analog, somatostatin recpetor scintigraphy ,